BioCentury
ARTICLE | Clinical News

QR-010: Phase Ib started

August 3, 2015 7:00 AM UTC

ProQR began the double-blind, placebo-controlled, international Phase Ib PQ-010-001 trial to evaluate single and multiple ascending doses of inhaled QR-010 in 64 patients who are homozygous for the de...